Mineralys Therapeutics Inc. monthly returns
Mineralys Therapeutics Inc. has averaged 5.46% per month, positive in 44% of months. Month-by-month returns for Mineralys Therapeutics Inc. (MLYS) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Mineralys Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -19.2% | |
| Sep 2026 | -2.1% | |
| Aug 2026 | +0.6% | |
| Jul 2026 | -5.4% | |
| Jun 2026 | -14.3% | |
| May 2026 | +18.2% | |
| Apr 2026 | -1.6% | |
| Mar 2026 | -7.4% | |
| Feb 2026 | -5.3% | |
| Jan 2026 | -14.9% | |
| Dec 2025 | -15.8% | |
| Nov 2025 | +5.5% | |
| Oct 2025 | +7.8% | |
| Sep 2025 | +145.0% | |
| Aug 2025 | +9.4% | |
| Jul 2025 | +4.6% | |
| Jun 2025 | -13.2% | |
| May 2025 | +9.6% | |
| Apr 2025 | -10.5% | |
| Mar 2025 | +73.7% | |
| Feb 2025 | -11.3% | |
| Jan 2025 | -16.3% | |
| Dec 2024 | -3.6% | |
| Nov 2024 | -4.6% | |
| Oct 2024 | +10.5% | |
| Sep 2024 | -2.4% | |
| Aug 2024 | +0.2% | |
| Jul 2024 | +5.9% | |
| Jun 2024 | -8.4% | |
| May 2024 | +4.2% | |
| Apr 2024 | -5.1% | |
| Mar 2024 | -16.1% | |
| Feb 2024 | +41.0% | |
| Jan 2024 | +26.9% | |
| Dec 2023 | +29.1% | |
| Nov 2023 | -13.8% | |
| Oct 2023 | -18.7% | |
| Sep 2023 | -25.9% | |
| Aug 2023 | -9.1% | |
| Jul 2023 | -17.1% | |
| Jun 2023 | +17.3% | |
| May 2023 | +8.1% | |
| Apr 2023 | -14.1% | |
| Mar 2023 | -11.9% |
Monthly total return (since Jan 2024)#
Mineralys Therapeutics Inc. returns by calendar month#
Every month of every year since 2024, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -19.22% — 3rd of 3 Octobers since 2024 at the last close; the average October returned +9.1%.
| Month | −145%0+145% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -1.4% | -14.9% | 33% | +26.9% 2024 | -16.3% 2025 | |
| Feb | +8.1% | -5.3% | 33% | +41.0% 2024 | -11.3% 2025 | |
| Mar | +16.8% | -7.4% | 33% | +73.7% 2025 | -16.1% 2024 | |
| Apr | -5.8% | -5.1% | 0% | -1.6% 2026 | -10.5% 2025 | |
| May | +10.7% | +9.6% | 100% | +18.2% 2026 | +4.2% 2024 | |
| Jun | -12.0% | -13.2% | 0% | -8.4% 2024 | -14.3% 2026 | |
| Jul | +1.7% | +4.6% | 67% | +5.9% 2024 | -5.4% 2026 | |
| Aug | +3.4% | +0.6% | 100% | +9.4% 2025 | +0.2% 2024 | |
| Sep | +46.8% | -2.1% | 33% | +145.0% 2025 | -2.4% 2024 | |
| Oct | +9.1% | +9.1% | 100% | +10.5% 2024 | +7.8% 2025 | |
| Nov | +0.5% | +0.5% | 50% | +5.5% 2025 | -4.6% 2024 | |
| Dec | -9.7% | -9.7% | 0% | -3.6% 2024 | -15.8% 2025 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from MLYS's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Mineralys Therapeutics Inc.'s average monthly return?
- Mineralys Therapeutics Inc. (MLYS) has averaged about 5.46% per month, positive in roughly 44% of months. The best month was Sep 2025 (+145.0%) and the worst was Oct 2026 (-19.2%).